Sign in with Google. Opens in new tab
bearish
Pre-IPO Bayzed Health Group (PHIP Updates) - Some Points Worth the Attention
301 Views16 Jun 2025 00:55
The positioning of Bayzed is just “a supplement to public hospital system”, with limited competitiveness.Due to weak profitability, it's hard to bring good returns.Valuation should be lower than peers
What is covered in the Full Insight:
- Introduction to Bayzed Health Group
- Current Market Position and Competitiveness
- Financial Performance and Profitability Issues
- Valuation and Risk of Goodwill Impairment
- Conclusion and Investment Recommendations
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Related Insights
More »Loading
Trending Collections
More »Trending Insights
More »- Solactive Global Uranium & Nuclear Components Index Rebalance: Two Adds & US$1.4bn Trade
- [Japan Activism/M&A] Hogy Medical (3593) Reportedly Up For Auction - Totally Unsurprising
- Nikkei 225 Index Rebalance Preview (Sep 2025): Potential Adds, Deletes, PAF, Capping & Other Changes
- [Japan LolWut?] Ikuyo (7273) Says "Iku Yo!" - Bitcoin, M&A, Weirdness, More
- GF Securities (1776 HK): Global Index Inclusion as Sector Rallies
Top Unpaywalled Insights
More »Loading
Discussions
(Paid Plans Only)
Top 5%
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
Price Chart(Sign Up to Access)
- Pre-IPO Bayzed Health Group (PHIP Updates) - Some Points Worth the Attention16 Jun 2025
- Sichuan Kelun-Biotech Biopharm (6990.HK) Placement - Thoughts The Pipeline and Valuation Outlook09 Jun 2025
- China Healthcare Weekly (Jun.8)-Summit/Akeso, Giant Biogene's Trouble, Views on Newtrend IPO Pricing08 Jun 2025
- Pre-IPO Bayzed Health Group - Here Are the Concerns and Potential Risks27 Jun 2024
x